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Background: The incidence of type 1 diabetes mellitus (T1DM) among children is high in Europe and the USA and relatively low 
in Asia, including Korea. The present study aimed to investigate the incidence and prevalence of childhood-onset T1DM in Korea 
and examine trends in incidence.
Methods: This study was conducted using the national registry data provided by the Health Insurance Review and Assessment 
Service in Korea from 2007 to 2017. We included children aged 0 to 14 years who were newly registered with a T1DM diagnosis 
each year (code E10).
Results: A total of 29,013 children were registered. The overall incidence of T1DM was 4.45 per 100,000 persons (girls, 4.93; boys, 
4.01). The overall incidence of childhood-onset T1DM in Korea increased from 3.70 in 2008 to 4.77 in 2016 (P=0.002). The inci-
dence of T1DM increased from 3.07 in 2008 to 4.89 in 2016 (P<0.001) among boys. Although the incidence of the disease in-
creased significantly among boys aged 5–9 and 10–14 years, it remained constant among girls (4.39 in 2008, 4.64 in 2016). The 
overall prevalence of childhood-onset T1DM in Korea increased from 32.85 in 2007 to 41.03 per 100,000 persons in 2017 (girls, 
35.54 to 43.88; boys, 32.85 to 41.03). 
Conclusion: We calculated relatively accurate incidence and prevalence of childhood-onset T1DM from a nation-based registry. The 
incidence increased by 3% to 4% every year from 2007 to 2017. The increasing trend is noteworthy compared with previous reports.
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INTRODUCTION
Childhood-onset type 1 diabetes mellitus (T1DM) is a preva-
lent pediatric endocrine disease. The incidence and prevalence 
of T1DM among children are high in Europe (particularly in 
Scandinavian countries) and the United States of America and 
relatively low in Asia. The incidence of childhood-onset T1DM 
has remained less eminent in Asia than in Western countries 
owing to the paucity of long-term data obtained from popula-
tion-based studies conducted in Asian countries, including 
Korea [1].
An increasing trend in the incidence of childhood-onset 
T1DM has been reported worldwide. The Diabetes Mondiale 
(DiaMond) Project Group reported an annual increase in 
T1DM incidence of 2.8% between 1990 and 1999 [2]. The Eu-
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dence of T1DM in Europe increased by approximately 3.9% 
annually between 1989 and 2003 [3]. The incidence and preva-
lence of T1DM and type 2 diabetes mellitus (T2DM) are in-
creasing in many developing countries [4,5]. However, recent 
reports emanating from some countries suggest that this in-
creasing trend has slowed. Studies conducted in Finland and 
Sweden demonstrated that the incidence of childhood-onset 
T1DM has ceased to increase in recent years [6,7]. In Norway, 
there was no significant increase in incidence between 2004 
and 2012 [8]. Epidemiological data on T1DM among children 
and adolescents are still lacking for most of the global popula-
tion, particularly in Africa, Asia, and South America [2]. Few 
comprehensive population-based studies of diabetes have in-
vestigated children and adolescents of diverse ethnic back-
grounds. A few studies have forecasted that the prevalence of 
childhood-onset T1DM will increase mostly in developing 
countries, even though the incidence has remained low [9,10]. 
Surveillance of the incidence and prevalence of childhood-on-
set T1DM should be conducted not only to understand its 
complex etiology but also to recognize the implications for 
public health [11].
Although several epidemiologic studies have been conduct-
ed, it is unclear whether the estimates of incidence and preva-
lence of T1DM among children and adolescents are accurate 
and whether the incidence is increasing in Korea. The present 
study aimed to investigate the incidence and prevalence of 
childhood-onset T1DM in Korea using the nationwide registry 
data provided by the Health Insurance Review and Assessment 
Service (HIRA). We also investigated the annual trend in the 
incidence of childhood-onset T1DM during the past decade 
and analyzed the data according to age and sex.
METHODS
Patients and study design
The present retrospective population-based study aimed to in-
vestigate the incidence and prevalence of childhood-onset 
T1DM among Korean children through a complete enumera-
tion survey using the HIRA claims data from January 1, 2007 
to December 31, 2017. The study design and enrollment of 
subjects are shown in Fig. 1. Korea has a national health insur-
ance system that provides medical insurance coverage to all its 
inhabitants, and each individual is registered with a health in-
surance identification number. Every resident is eligible re-
gardless of nationality or profession. The system is funded by 
compulsory contributions from all residents and government 
subsidies. All Korean patients who visit a hospital are regis-
tered with a diagnosis according to the World Health Organi-
Fig. 1. Study design and number of subjects for investigating the incidence of type 1 diabetes mellitus (T1DM) in Korean chil-
dren. ICD-10, World Health Organization’s International Classifications of Diseases, Tenth Revision.
Subjects with diagnosis of T1DM (E10 according to 
ICD-10) before 15 years of age with insulin treatment 
from 2008 to 2016 (n=12,332)
Number of subjects (n=10,866)
Number of subjects (n=4,720)
Number of subjects for incidence of T1DM in this study 
(n=3,094)
Subjects with insulin treatment from 
Jan. 2007 to Dec. 2007 (n=1,466)
No more insulin treatment within a 
year after diagnosis (n=7,612)
No further insulin treatment from 1 
to 2 years after diagnosis (n=1,626)
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zation’s International Classifications of Diseases, Tenth Revi-
sion (ICD-10). The HIRA reviews the data to ensure proper 
diagnoses and management and to assess the quality of health-
care and medical fees. 
In calculating the incidence of T1DM, we included boys and 
girls who were newly registered with a diagnostic code of E10 
according to the ICD-10 before the age of 15 years and were 
treated only with insulin, as done in other studies of the pedi-
atric population. We excluded children who were injected with 
insulin before 2008 and patients who were not treated with in-
sulin continuously for 2 consecutive years after diagnosis to 
rule out patients with T2DM. In estimating the prevalence, we 
included children who were registered with a diagnostic code 
of E10 before the age of 15 years and received at least two pre-
scriptions of insulin over 12 months with continuous insulin 
treatment in the following year. The diagnosis of T1DM was 
confirmed with a thorough review of the medical records of all 
cases by medical personnel of the HIRA. 
Ethics statement
The study adhered to the tenets of the Declaration of Helsinki. 
The study protocol was approved by the Institutional Review 
Board of Severance Hospital, Seoul, Korea, and written in-
formed consents from the subjects were exempted by the IRB 
(no. 4-2019-0088).
Calculation of incidence and prevalence 
We calculated the incidence of T1DM by dividing the number 
of children who were newly diagnosed with T1DM during a 
calendar year by the total number of children at risk living in 
Korea during that calendar year. Exact confidence intervals for 
incidence were calculated using the Ulm’s formula [12]. In ad-
dition, we calculated the prevalence of T1DM by dividing the 
number of children registered with a diagnosis of T1DM dur-
ing a calendar year by the total number of children living in Ko-
rea during that calendar year. The 95% confidence intervals of 
the prevalence with a 0.05 significance level were also calculated 
using the formula  (where, p is the prevalence 
and n is the sample size). Gender- and age-specific incidence 
and prevalence of T1DM were calculated using the population 
data obtained from the Korean Statistical Information Service, 
2015 (http://kosis.kr/). Both the incidence and prevalence were 
calculated per 100,000 inhabitants according to age and gen-
der. A Cochran–Armitage test for trend was used to investigate 
and compare the time trends in incidence by sex and age group 
(0–4, 5–9, and 10–14 years). Analysis items with P<0.05 were 
considered statistically significant.
RESULTS
A total of 29,013 children were registered from January 2007 to 
December 2017. The annual incidences of T1DM according to 
gender from 2008 to 2016 are shown in Table 1. The overall in-
cidence of T1DM during the study period was 4.45 per 100,000 
persons (girls, 4.93; boys, 4.01). The overall incidence of child-
hood-onset T1DM in Korea increased significantly from 3.70 





cases Population Incidence (CI)
No. of 
cases Population Incidence (CI)
No. of 
cases Population Incidence (CI)
2008 181 4,120,183 4.39 (3.78–5.08) 139 4,521,648 3.07 (2.58–3.63) 320 8,881,760 3.70 (3.31–4.13)
2009 183 4,009,329 4.56 (3.93–5.28) 163 4,374,659 3.73 (3.18–4.34) 346 8,641,831 4.13 (3.70–4.59)
2010 200 3,898,029 5.13 (4.44–5.89) 155 4,231,154 3.66 (3.11–4.29) 355 8,383,987 4.37 (3.92–4.85)
2011 223 3,799,250 5.87 (5.12–6.69) 172 4,106,239 4.19 (3.59–4.86) 395 8,129,182 5.00 (4.52–5.51)
2012 175 3,710,279 4.72 (4.04–5.47) 155 3,998,855 3.88 (3.29–4.54) 330 7,905,489 4.28 (3.83–4.77)
2013 185 3,624,293 5.10 (4.40–5.90) 161 3,897,014 4.13 (3.52–4.82) 346 7,709,134 4.60 (4.13–5.11)
2014 195 3,541,088 5.51 (4.76–6.34) 163 3,795,828 4.29 (3.66–5.01) 358 7,521,307 4.88 (4.39–5.41)
2015 153 3,457,143 4.43 (3.75–5.19) 158 3,694,212 4.28 (3.64–5.00) 311 7,336,916 4.35 (3.88–4.86)
2016 157 3,380,577 4.64 (3.95–5.43) 176 3,601,440 4.89 (4.19–5.66) 333 7,151,354 4.77 (4.27–5.31)
CI, confidence interval.
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per 100,000 persons in 2008 to 4.77 per 100,000 persons in 
2016 (P=0.002). The incidence of T1DM among boys in-
creased from 3.07 per 100,000 persons in 2008 to 4.89 per 
100,000 persons in 2016 (P<0.001). However, the incidence 
was not definite among girls during the study period (4.39 per 
100,000 persons in 2008 and 4.64 per 100,000 persons in 2016). 
There was an increasing trend in gender-specific annual inci-
dence of childhood-onset T1DM in Korea (Fig. 2). The inci-




























No. of cases 2008 16 48 117 181 13 25 101 139 29 73 218 320
2009 21 60 102 183 17 45 101 163 38 105 203 346
2010 23 60 117 200 20 37 98 155 43 97 215 355
2011 22 59 142 223 21 48 103 172 43 107 245 395
2012 16 50 109 175 19 35 101 155 35 85 210 330
2013 27 46 112 185 16 39 106 161 43 85 218 346
2014 35 49 111 195 22 35 106 163 57 84 217 358
2015 26 42 85 153 23 34 101 158 49 76 186 311
2016 15 56 86 157 20 45 111 176 35 101 197 333
Incidence 2008 1.44 3.49 7.17 4.39 1.09 1.66 5.53 3.07 1.26 2.53 6.30 3.70
2009 1.91 4.59 6.37 4.56 1.45 3.16 5.69 3.73 1.67 3.84 6.02 4.13
2010 2.08 4.89 7.47 5.13 1.70 2.78 5.69 3.66 1.88 3.79 6.53 4.37
2011 1.96 5.12 9.31 5.87 1.76 3.85 6.18 4.19 1.86 4.46 7.68 5.00
2012 1.42 4.43 7.50 4.72 1.59 2.88 6.37 3.88 1.51 3.62 6.91 4.28
2013 2.41 4.08 8.14 5.10 1.35 3.23 7.06 4.13 1.86 3.64 7.58 4.60
2014 3.13 4.39 8.49 5.51 1.86 2.94 7.44 4.29 2.48 3.64 7.94 4.88
2015 2.34 3.75 6.93 4.43 1.97 2.85 7.59 4.28 2.15 3.28 7.27 4.35
2016 1.38 4.92 7.46 4.64 1.75 3.72 8.90 4.89 1.57 4.30 8.21 4.77
Cochran–Armitage test for trend 0.263 0.722 0.408 0.724 0.153 0.040 <0.001 <0.001 0.072 0.103 <0.001 0.002
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cases Population Prevalence (CI) 
No. of 
cases Population Prevalence (CI) 
No. of 
cases Population Prevalence (CI) 
2007 1,501 4,223,530 35.54 (33.76–37.38) 1,417 4,658,230 30.42 (28.86–32.05) 2,918 8,881,760 32.85 (31.67–34.07)
2008 1,466 4,120,183 35.58 (33.78–37.45) 1,361 4,521,648 30.10 (28.52–31.74) 2,827 8,641,831 32.71 (31.52–33.94)
2009 1,416 4,009,329 35.32 (33.50-37.21) 1,337 4,374,659 30.56 (28.95–32.25) 2,753 8,383,987 32.84 (31.62–34.09)
2010 1,403 3,898,029 35.99 (34.13–37.93) 1,305 4,231,154 30.84 (29.19–32.56) 2,708 8,129,182 33.31 (32.07–34.59)
2011 1,374 3,799,250 36.17 (34.28–38.13) 1,233 4,106,239 30.03 (28.37–31.75) 2,607 7,905,489 32.98 (31.72–34.27)
2012 1,400 3,710,279 37.73 (35.78–39.76) 1,260 3,998,855 31.51 (29.79–33.30) 2,660 7,709,134 34.50 (33.21–35.84)
2013 1,288 3,624,293 35.54 (33.62–37.53) 1,116 3,897,014 28.64 (26.98–30.37) 2,404 7,521,307 31.96 (30.70–33.27)
2014 1,298 3,541,088 36.66 (34.69–38.71) 1,117 3,795,828 29.43 (27.73–31.20) 2,415 7,336,916 32.92 (31.62–34.26)
2015 1,201 3,457,143 34.74 (32.80–36.76) 1,109 3,694,212 30.02 (28.28–31.84) 2,310 7,151,354 32.30 (31.00–33.65)
2016 1,361 3,380,577 40.26 (38.15–42.46) 1,242 3,601,440 34.49 (32.59–36.46) 2,603 6,982,017 37.28 (35.86–38.74)
2017 1,456 3,318,119 43.88 (41.66–46.19) 1,352 3,526,103 38.34 (36.33–40.44) 2,808 6,844,221 41.03 (39.52–42.57)
CI, confidence interval.
dence increased by approximately 3% to 4% every year from 
2007 to 2017.
The annual incidence of T1DM according to gender and age 
group is shown in Table 2. The overall incidence of childhood-
onset T1DM increased significantly among children aged 10 to 
14 years. The incidence increased significantly among boys 
aged 5–9 and 10–14 years; however, it was indefinite among 
boys aged 0 to 4 years. The incidence of T1DM increased from 
1.16 to 3.72 per 100,000 persons among boys aged 5 to 9 years 
and from 5.53 to 8.90 per 100,000 persons among boys aged 10 
to 14 years between 2008 and 2016 (P=0.040 and P<0.001, re-
spectively). The incidence of T1DM among girls did not in-
crease significantly in all age groups. 
The distribution of the annual prevalence of T1DM accord-
ing to age group is shown in Table 3. The overall prevalence of 
childhood-onset T1DM in Korea increased significantly from 
32.85 to 41.03 per 100,000 persons between 2007 and 2017 
(girls, 35.54 to 43.88 per 100,000 persons; boys, 32.85 to 41.03 
per 100,000 persons). The annual prevalence increased rapidly 
over the last 2 years of the study period.
We analyzed the cumulative distribution of the incidence of 
disease according to months from 2008 to 2016. The incidence 
Fig. 3. Distribution of type 1 diabetes mellitus among Korean children according to month from 2008 to 2016.
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appeared to be relatively high in March, April, and June and 
low in November and December. However, this seasonal dif-
ference was not significant statistically (Fig. 3).
DISCUSSION
This work was a retrospective national registry-based epidemi-
ologic study of the incidence and prevalence of childhood-on-
set T1DM in Korea from 2007 to 2017. The overall incidence 
of childhood-onset T1DM during the study period was 4.45 
per 100,000 persons (girls, 4.93; boys, 4.01). The overall inci-
dence of childhood-onset T1DM in Korea (per 100,000 per-
sons) increased significantly from 3.70 in 2008 to 4.77 in 2016 
and by approximately 3% to 4% annually during the study pe-
riod. The overall prevalence (per 100,000 persons) increased 
significantly from 32.85 in 2007 to 41.03 in 2017 (girls, 35.54 to 
43.88; boys, 32.85 to 41.03). We found that the incidence and 
prevalence of childhood-onset T1DM in Korea were higher 
than those determined in previous studies conducted in Korea 
and increased significantly during the study period.
The global incidence of diabetes among children and adoles-
cents is increasing rapidly due to an increase in incidence of 
childhood obesity regardless of region. However, there are 
some variations in the incidence of T1DM according to ethnic-
ity and region. Approximately 193,000 Americans younger 
than 20 years are estimated to have been diagnosed with diabe-
tes, representing approximately 0.24% of that population [13]. 
A nationwide survey conducted in the USA from 2001 through 
2016 demonstrated that 45,047 people aged 19 or younger who 
had T1DM were identified, representing a 5.4 to 79.6 preva-
lence rate per 100,000 person-years according to the states 
[13]. The DiaMond Project Group reported that a very high 
incidence was found in European countries and North Ameri-
ca, and the lowest incidence was found in the populations from 
China and South America in 2000 [14]. The EURODIAB study 
reported the incidence of childhood-onset T1DM in the first 
(1989 to 1998) and second (1999 to 2008) halves of the 20-year 
period. The increase in annual incidence rates were similar 
(3.4% and 3.3%, respectively), suggesting that the incidence 
rate of childhood-onset T1DM continues to rise across Europe 
but not uniformly so among the regions [15]. 
Asian countries showed relatively lower incidences of child-
hood-onset T1DM than did Europe and the USA. These geo-
graphic differences in T1DM incidence may reflect population 
variations in the frequency of T1DM susceptibility or protec-
tive genes and/or environmental factors or their combination 
[16]. Although the incidence of T1DM is relatively lower in 
Asian countries, increasing trends in the incidence of T1DM 
have also been observed in Asian regions. In Japan, the annual 
incidence of childhood-onset T1DM was 1.5 per 100,000 per-
sons from 1986 to 1990 [17]. A more recent study conducted 
in Japan reported that the incidence of T1DM from 2005 to 
2010 was 2.25 per 100,000 persons, suggesting that the inci-
dence is increasing in Japan [1]. In China, the incidence in the 
Beijing area was 1.81 per 100,000 population during 2003 to 
2010 [18]. In reports of a Taiwanese nationwide epidemiologic 
study, the incidence of childhood-onset T1DM (per 100,000 
persons) was 3.56 among boys and 5.88 among girls in 1999 to 
2000 and increased significantly with an incidence of 4.42 
among boys and 6.92 among girls in 2009 to 2010 [19]. The 
present study showed higher incidence of T1DM in Korea 
compared with that of Japan and China, and lower than that of 
Taiwan. The incidence and prevalence of T1DM would differ 
from country to country due to variable factors including 
change of lifestyle, increase of obesity, and environmental im-
mune system [20,21]. 
It is known that the incidence of childhood-onset T1DM is 
exceptionally low in Korea. A limited number of studies have 
estimated the incidence and prevalence of childhood-onset 
T1DM in Korea. The first nationwide survey on the incidence 
of T1DM among Korean children and adolescents was con-
ducted as part of the Diabetes Epidemiology Research Interna-
tional Study from 1985 to 1986 and showed an incidence of 0.5 
per 100,000 population in both sexes [22]. Another study re-
ported an incidence of 1.36 per 100,000 during 1995 to 2000 
[23]. The most recent report on the epidemiology of child-
hood-onset T1DM in Korea was performed using the data ob-
tained from the National Health Insurance Service during 
2012 to 2014 [24]. The incidence was 3.19 per 100,000 (2.84 
and 3.56 among boys and girls, respectively), and it was rela-
tively higher than that reported in previous studies conducted 
in Korea. The present study demonstrated a higher incidence 
and prevalence than previously reported estimates in Korea 
and a significant increase in incidence of childhood-onset 
T1DM. We confirmed that the increasing trend in incidence of 
childhood-onset T1DM was sustained in Korea. 
In the present study, we found a higher incidence and preva-
lence among girls than among boys. However, the increase in 
the rate of incidence was higher among boys. It is known that 
boys are predominantly affected by T1DM after puberty [25]. 
Chae HW, et al.
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The overall ratio of incidence of T1DM among boys to that 
among girls was 1:1; however, a ratio of 1:7 was reported among 
children aged 13 years in a study conducted in Finland [26]. 
Some reports have shown that childhood-onset T1DM is more 
common among male children and adolescents in European 
countries [27-29]. Compared with that of Western countries, 
the Japanese cohort presents a preponderance of girls than 
boys [17]. A report emanating from China showed a prepon-
derance of girls with newly diagnosed T1DM; however, a 
higher rate of increase occurred among boys between 1995 
and 2010, similar to that observed in the present study [30]. A 
report showed that female predominance is associated with a 
lower incidence and ethnic group [27]. This implies that there 
should be specific considerations according to certain ethnici-
ties or regions, although the reasons remain to be clarified.
In the present study, the incidences of childhood-onset 
T1DM appeared to be higher in March, April, and June; how-
ever, this seasonal difference was not significant statistically. It 
has been reported that the incidence of T1DM is higher in the 
fall or winter seasons [31,32]. However, the seasonality pattern 
appears to depend on the geographical location, at least as far 
as the hemisphere dichotomy is concerned [33]. A Japanese 
cohort study revealed no seasonal variation compared with 
that of Western countries [17].
We found that the incidence of childhood-onset T1DM in 
Korea increased rapidly over the past decade. It is unclear why 
the incidence of childhood-onset T1DM is increasing in Ko-
rea; nevertheless, it is not remarkably higher than that of West-
ern countries. Factors contributing to the development of 
T1DM include genetic factors, which involve familial and eth-
nic patterns, and various environmental factors. A westernized 
lifestyle and national prosperity could reflect differences in en-
vironmental risk factors such as nutrition or lifestyle that affect 
the incidence rate [34]. The “accelerator hypothesis” tried to 
explain the loss of beta cells and the increasing incidence of 
both types of diabetes associated with the childhood obesity 
epidemic in some way [35]. An increasing prevalence of obesi-
ty among Korean children may also yield a possible association 
with the increasing rate of childhood-onset T1DM [36]. An 
assessment of the risk factors for T1DM in the general popula-
tion and further efforts aimed at elucidating the causes under-
lying the increase in incidence of T1DM among Korean chil-
dren are needed.
Our study had some limitations. First, some T1DM patients 
might not be registered for various reasons, such as emigration 
or studying abroad. Second, there is a possibility of misclassifi-
cation of childhood T1DM or T2DM. For example, early treat-
ments of T2DM often include insulin injections besides oral 
hypoglycemic agents. We tried to exclude patients who were 
not treated with insulin continuously for 2 consecutive years 
after diagnosis; nonetheless, misclassification might be a con-
founding factor in the present study. Third, the prevalence 
might be overestimated. We included children who were regis-
tered with a diagnostic code of E10 and were treated with only 
insulin continuously more than once; however, we could not 
perfectly exclude some cases of T2DM. Despite these limita-
tions, we believe that the inclusion and exclusion criteria in the 
present study might be the most practical way to achieve the 
study aim and we were able to calculate relatively accurate inci-
dences and prevalence of childhood-onset T1DM using the 
nationwide data.
In conclusion, we calculated relatively accurate incidences 
and prevalence of childhood-onset T1DM according to the 
data obtained from a nationwide registry from the HIRA. We 
found that the incidence and prevalence of childhood-onset 
T1DM increased significantly at a rate of about 3% to 4% every 
year from 2007 to 2017. Further long-term studies with inves-
tigation of environmental factors and other possible contribut-
ing factors are needed to elucidate the increasing trend in the 
occurrence of childhood-onset T1DM in Korea.
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